The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online August 10, 2009
The Journal of Immunology, 2009, 183, 2915 -2920
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0801607

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0801607v1
183/5/2915    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gallagher, K. M. E.
Right arrow Articles by Godkin, A. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallagher, K. M. E.
Right arrow Articles by Godkin, A. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Type I Interferon (IFN{alpha}) Acts Directly on Human Memory CD4+ T Cells Altering Their Response to Antigen1

Kathleen M. E. Gallagher2, Sarah Lauder2, Ian W. Rees, Awen M. Gallimore and Andrew J. Godkin3

Department of Medical Biochemistry and Immunology, The Henry Wellcome Building, Cardiff University, Cardiff, United Kingdom

Despite its use widely as a therapeutic agent, and proposed use as vaccine adjuvant, the effect of IFN{alpha} on T cell function is poorly understood. As a pleiotropic innate cytokine produced rapidly in response to pathogens, it is well placed to impinge on specific immune responses. The aim of this study was to examine the impact of IFN{alpha} on the function of human memory CD4+ T cells using the recall Ags purified protein derivative, tetanus toxoid, and hemagglutinin. IFN{alpha} administered either in vivo or added exogenously in vitro tended to enhance proliferative responses of purified protein derivative-specific T cells in marked contrast to the other cognate populations whose responses were often diminished. Purifying the memory CD4+CD45RO+ T cells confirmed IFN{alpha} acted directly on these cells and not via an intermediate. The T cells could be divided into two broad categories depending on how IFN{alpha} effected their responses to cognate Ag: 1) enhanced proliferation and a striking increase in IFN{gamma}-production compared with smaller increases in IL-10 (increased ratio of IFN{gamma}:IL-10), and 2) neutral or diminished proliferation coupled with a smaller increase in IFN{gamma} relative to the increase in IL-10 (reduced IFN{gamma}:IL-10 ratio). IFN{alpha} has a role in modifying memory T cell responses when they are exposed to cognate Ag and may be important in vaccination strategies designed to augment particular Th memory responses.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

A.J.G. designed the research. K.G., S.L., and I.W.R. performed the research. K.M.E.G., A.M.G., and A.J.G. analyzed the data. K.M.E.G., A.M.G., and A.J.G. wrote the paper.

1 This work was supported by research grants from Roche Pharmaceuticals, and Cardiff and Vale National Health Service Trust Research and Development department. A G. is a Medical Research Council Senior Fellow. Authors declare they have no financial conflict of interest.

2 K.G. and S.L. contributed equally to this study.

3 Address correspondence and reprint requests to Dr. Andrew. J. Godkin, Department of Medical Biochemistry and Immunology, The Henry Wellcome Building, Cardiff University, Heath Park, Cardiff, United Kingdom. E-mail address: wmdajg{at}groupwise.cf.ac.uk

4 Abbreviations used in this paper: HCV, hepatitis C virus; PPD, purified protein derivative; TT, tetanus toxoid; HA, hemagglutinin.

5 The online version of this article contains supplementary material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.